Pharmaceutical composition for administration to nails
The invention provides semi-solid or liquid pharmaceutical compositions for topical administration to a finger- or toenail of a human. The compositions are useful for the delivery of active ingredients deep into the nail. Various active ingredients may be incorporated, such as antifungal agents, anti-infectives, anti-inflammatory agents, immunosuppressants, local anesthetics, and retinoids.
1. A method for the treatment of a disease or condition affecting a nail, comprising administering to the nail a topical pharmaceutical composition comprising
an effective amount of an active ingredient which is (i) an immunosuppressant selected from the group consisting of tacrolimus, sirolimus, everolimus, pimecrolimus, ridaforolimus, temsirolimus, zotarolimus, and ciclosporin A, or (ii) an antifungal agent selected from the group consisting of clotrimazole, ketoconazole, miconazole, terbinafine, naftifine, butenafine, ciclopiroxolamine and amorolfine, and
a semifluorinated alkane according to formula
RFRH
or
RFRHRF
wherein: RF is a perfluorinated hydrocarbon segment with 20 or less carbon atoms, and RH is a non-fluorinated hydrocarbon segment with 3 to 20 carbon atoms.
2. The method of claim 1 , wherein the semifluorinated alkane is a compound of formula
RFRH
wherein RF is a linear perfluorinated hydrocarbon segment with 4 to 12 carbon atoms, and wherein RH is a linear alkyl group with 4 to 8 carbon atoms.
3. The method of claim 2 , wherein the semifluorinated alkane is selected from F4H5, F4H6, F4H8, F6H6 and F6H8.
4. The method of claim 1 , wherein the composition is in the form of a liquid or semisolid solution, gel, spray, emulsion, suspension, microemulsion, nail lacquer, or patch.
5. The method of claim 1 , wherein the composition comprises a physiologically acceptable cosolvent selected from ethanol, acetone, ethyl acetate, isopropyl alcohol, glycerol, propylene glycol, pentylene glycol, polyethylene glycol, liquid paraffin, triglyceride oils, hydrofluorocarbons, and liquid mono- or diglycerides.
6. The method of claim 1 , wherein the nail is affected by nail psoriasis, and wherein the active ingredient is an immunosuppressant.
7. The method of claim 1 , wherein the nail is affected by onychomycosis and wherein the active ingredient is an antifungal agent.
8. The method of claim 1 , wherein the nail is a fingernail.
9. The method of claim 1 , wherein the nail is a toe-nail.
10. The method of claim 3 , wherein the nail is affected by nail psoriasis and wherein the active ingredient is an immunosuppressant.
11. The method of claim 3 , wherein the nail is affected by onychomycosis and wherein the active ingredient is an antifungal agent.
12. The method of claim 1 wherein the active ingredient is tacrolimus.
13. The method of claim 1 wherein the active ingredient is ciclopiroxolamine.